BHC three-lens brief
Evidence-based stock research on BHC. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Outperforming SPY by 25.8pp over 30 days.
- Outperforming SPY by 25.8pp over 30 days.
- Analyst mean target $7.50 — 24% above current (5 analysts).
BHC closed at $6.07 (-1.46%) as of 2026-09-11. Market cap: $2.27B. P/E (trailing) 13.3. Price is above the 50-day MA and above the 200-day MA. Positives: outperforming SPY by 25.8pp over 30 days.; analyst mean target $7.50 — 24% above current (5 analysts).. Last quarter: Revenue $2.85B, net income $258.00M, free cash flow $1.43B.
Why three lenses on BHC, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BHCacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/BHC" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BHC brief"></iframe>